Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUET II
2015-002161-27Phase 2Active
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Feb 2016
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of urokinase in arterial thromboembolism and Acute ischemia (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Thrombolysis-induced hemorrhagic complications. Started Feb 2016; status: active.
02
Drugs
urokinase
03
Conditions
arterial thromboembolismAcute ischemia
Beyond the preview
Go deeper on 2015-002161-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002161-27.